In vitro effects of N-acetyl cysteine alone and in combination with antibiotics on Prevotella intermedia

다국어 초록 (Multilingual Abstract)

N-acetyl cysteine (NAC) is an antioxidant that possesses anti-inflammatory activities in tissues. In the field of dentistry, NAC was demonstrated to prevent the expression of LPS-induced inflammatory mediators in phagocytic cells and gingival fibroblasts during the inflammatory process, but the effect of NAC on oral pathogens has been rarely studied. Here, we examined the effect of NAC against planktonic and biofilm cells of Prevotella intermedia, a major oral pathogen. NAC showed antibacterial activity against the planktonic P. intermedia with MIC value of 3 mg/ml and significantly decreased biofilm formation by the bacterium even at sub MIC. NAC did not affect the antibiotic susceptibility of planktonic P. intermedia, showing indifference (fractional inhibitory concentration index of 0.5–4) results against the bacterium in combination with ampicillin, ciprofloxacin, tetracycline or metronidazole. On the other hand, viability of the pre-established bacterial biofilm exposed to the antibiotics except metronidazole was increased in the presence of NAC. Collectively, NAC may be used for prevention of the biofilm formation by P. intermedia rather than eradication of the pre-established bacterial biofilm. Further studies are required to explore antibacterial and anti-biofilm activity of NAC against mixed population of oral bacteria and its modulatory effect on antibiotics used for oral infectious diseases.

참고문헌 (Reference)

1 Ehsani, M., "The role of prophylactic ibuprofen and N-acetylcysteine on the level of cytokines in periapical exudates and the post-treatment pain" 20 : 30-, 2012

2 Takahashi, N., "The effects of tetracycline, minocycline, doxycycline and ofloxacin on Prevotella intermedia biofilm" 21 : 366-371, 2006

3 Stey, C., "The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review" 16 : 253-262, 2000

4 Chong, A., "The early phagosomal stage of Francisella tularensis determines optimal phagosomal escape and Francisella pathogenicity island protein expression" 76 : 5488-5499, 2008

5 Honma, K., "The OxyR homologue in Tannerella forsythia regulates expression of oxidative stress responses and biofilm formation" 155 : 1912-1922, 2009

6 Ulrich, M., "Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis" 65 : 978-984, 2010

7 Lemos, J.A., "Protocols to study the physiology of oral biofilms" 666 : 87-102, 2010

8 Gokcimen, A., "Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity" 26 : 519-525, 2007

9 Schwandt, L.Q., "Prevention of biofilm formation by dairy products and N-acetylcysteine on voice prostheses in an artificial throat" 124 : 726-731, 2004

10 Ashimoto, A., "Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions" 11 : 266-273, 1996

11 Mombelli, A., "Persistence patterns of Porphyromonas gingivalis, Prevotella intermedia/nigrescens, and Actinobacillus actinomyetemcomitans after mechanical therapy of periodontal disease" 71 : 14-21, 2000

12 Albesa, I., "Oxidative stress involved in the antibacterial action of different antibiotics" 317 : 605-609, 2004

13 Becerra, M.C., "Oxidative stress induced by ciprofloxacin in Staphylococcus aureus" 297 : 1003-1007, 2002

14 Quah, S.Y., "Nacetylcysteine inhibits growth and eradicates biofilm of Enterococcus faecalis" 38 : 81-85, 2012

15 Goswami, M., "N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility" 54 : 3529-3530, 2010

16 Toker, H., "N-acetylcysteine, a thiol antioxidant, decreases alveolar bone loss in experimental periodontitis in rats" 80 : 672-678, 2009

17 Zhao, T., "N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa" 10 : 140-, 2010

18 Vercelino, R., "N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome" 102 : 370-376, 2008

19 Olofsson, A.C., "N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces" 69 : 4814-4822, 2003

20 Do Young Kim, "N-Acetylcysteine Prevents LPS-Induced Pro-inflammatory Cytokines and MMP2 Production in Gingival Fibroblasts" 대한약학회 30 (30): 1283-1292, 2007

21 Zafarullah, M., "Molecular mechanisms of N-acetylcysteine actions" 60 : 6-20, 2003

22 Falkler, W.A. Jr., "Microbiological understandings and mysteries of noma (cancrum oris)" 5 : 150-155, 1999

23 Jacinto, R.C., "Microbiological analysis of infected root canals from symptomatic and asymptomatic teeth with periapical periodontitis and the antimicrobial susceptibility of some isolated anaerobic bacteria" 18 : 285-292, 2003

24 Carvalho, I., "Microbial pathogens and strategies for combating them: science, technology and education" FORMATEX 170-178, 2013

25 CLSI, "Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard"

26 Hsu, H.Y., "Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression" 277 : 22131-22139, 2002

27 Rao, M.S., "Kinetic growth parameters of different amylolytic and non-amylolytic Lactobacillus strains under various salt and pH conditions" 94 : 331-337, 2004

28 Goswami, M., "Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli" 50 : 949-954, 2006

29 Kamberi, M., "Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin" 43 : 525-529, 1999

30 Pérez-Giraldo, C., "Influence of Nacetylcysteine on the formation of biofilm by Staphylococcus epidermidis" 39 : 643-646, 1997

31 Kaplan, M., "Influence of N-acetylcysteine on renal toxicity of cadmium in rats" 23 : 233-241, 2008

32 Maeda, N., "Incidence of Prevotella intermedia and Prevotella nigrescens in periodontal health and disease" 42 : 583-539, 1998

33 Barbee, L.A., "In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae" 69 : 1572-1578, 2014

34 Brook, I., "Immune response to Fusobacterium nucleatum and Prevotella intermedia in the sputum of patients with acute exacerbation of chronic bronchitis" 124 : 832-833, 2003

35 Fosse, T., "High prevalence of cfxAβ-lactamase in aminopenicillin-resistant Prevotella strains isolated from periodontal pockets" 17 : 85-88, 2002

36 Goswami, M., "Glutathione-mediated augmentation of β-lactam antibacterial activity against Escherichia coli" 60 : 184-185, 2007

37 Ross, D., "Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection" 37 : 231-249, 1988

38 Takahashi, N., "Glucose metabolism by Prevotella intermedia and Prevotella nigrescens" 15 : 188-195, 2000

39 Koussémon, M., "Glucose fermentation by Propionibacterium microaerophilum: effect of pH on metabolism and bioenergetic" 46 : 141-145, 2003

40 Ali, K.F., "Estimation and evaluation of the effect of pH on ciprofloxacin in drug formulations" 6 : 910-916, 2014

41 Alkawareek, M.Y., "Eradication of Pseudomonas aeruginosa biofilms by atmospheric pressure non-thermal plasma" 7 : e44289-, 2012

42 Leke, N., "Effects of hydrogen peroxide on growth and selected properties of Porphyromonas gingivalis" 174 : 347-353, 1999

43 Goswami, M., "Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli" 51 : 1119-1122, 2007

44 Takahashi, N., "Effect of pH on the growth and proteolytic activity of Porphyromonas gingivaiis and Bacteroides intermedius" 69 : 1266-1269, 1990

45 Marchese, A., "Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms" 22 : 95-100, 2003

46 Denny, T.P., "Characterization of Pseudomonas solanacearum Tn5 mutants deficient in extracellular polysaccharide" 1 : 215-223, 1988

47 Donlan, R.M., "Biofilms: Microbial life on surfaces" 8 : 881-890, 2002

48 Simmons, W.L., "Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin" 75 : 3696-3699, 2007

49 Bolivar, I., "Bacterial diversity in oral samples of children in Niger with acute noma, acute necrotizing gingivitis, and healthy controls" 6 : e1556-, 2012

50 Gomes, B.P., "Associations of specific bacteria with some endodontic signs and symptoms" 27 : 291-298, 1994

51 Gomes, B.P., "Associations of endodontic symptoms and signs with particular combinations of specific bacteria" 29 : 69-75, 1996

52 Scannapieco, F.A., "Associations between oral conditions and respiratory disease in a national sample survey population" 3 : 251-256, 1998

53 Rôças, I.N., "Association of Enterococcus faecalis with different forms of periradicular diseases" 30 : 315-320, 2004

54 Andrés, M.T., "Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain" 42 : 3022-3023, 1998

55 Moon, J.H., "Antibacterial and antibiofilm effects of iron chelators against Prevotella intermedia" 62 : 1307-1316, 2013

56 Moon, J.H., "Antibacterial action of polyphosphate on Porphyromonas gingivalis" 55 : 806-812, 2011

57 Takahashi, N., "Acid tolerance and acid-neutralizing activity of Porphyromonas gingivalis, Prevotella intermedia and Fusobacterium nucleatum" 12 : 323-328, 1997

58 Shinzato, T., "A mechanism of pathogenicity of “Streptococcus milleri group” in pulmonary infection: synergy with an anaerobe" 40 : 118-123, 1994

59 Lee, N.K., "A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation" 106 : 852-859, 2005